首页> 外文期刊>中国人民解放军军医大学学报(英文版) >Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells
【24h】

Role of liver X receptors alpha agonist on expressions of LPS-induced inflammatory response associated factor IRAK-4 and NF-kappaB in Kupffer cells

机译:肝X受体α激动剂在枯否细胞中LPS诱导的炎症反应相关因子IRAK-4和NF-κB表达上的作用

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To explore the role of activated liver X receptor a (LXRa) on the expressions of interleukin-1 receptor associated kinase-4 (IRAK-4) and NF-kappaB (NF-κB) in the inflammatory response which induced by LPS in the Kupffer cells and to investigate the possible mechanisms of LXRα negative regulation of inflammatory response. Methods: The Kupffer cells were isolated from male Kunming mice by collagen perfusion in situ. And these cells were divided into 4 groups: normal control group, LPS treatment group, LXRα agonist T0901317 treatment group, LPS and T0901317 combined treatment group. The LPS treatment group were treated with a final concentration of 1 μg/ml LPS in RPMI 1640 and cultured for 6 h, the T0901317 treatment group were treated with a final concentration of 5 μg/ml in RPMI 1640 and cultured for 24 h, and the combined treatment group received pre-culture for 24 h with a final concentration of 1 μg/ml T0901317 in RPMI 1640 and then cultured for 6 h with a final concentration of 5 μg/ml LPS in RPMI 1640. All groups were cultured for 30 h. The expression of LXRα, IRAK-4 and NF-κB at mRNA and protein levels were detected by real-time PCR and Western blotting, and the TNF-α and IL-1β levels were detected by ELISA. Results: The levels of LXRα mRNA and protein were highest in T0901317 group, and lowest in LPS group (P<0.05). The level of IRAK4 and NF-κB mRNAs and proteins were evidently lower in the Combined-treated group than in LPS group (P<0.05). And the level of TNF-α and IL-1 were observed highest in LPS group (P<0.05), but no difference among the Control group, T0901317 group and Combined-treated group (P>0.05). Conclusion: These date suggest that the LXR agonists can effectively up-regulate the expressions of LXRa mRNA and protein and inhibit the inflammatory response. This may be via down-regulating the expressions of IRAK4 and NF-κB at mRNA and protein levels.
机译:目的:探讨活化的肝X受体α(LXRa)对白细胞介素1受体相关激酶4(IRAK-4)和NF-κB(NF-κB)表达的影响。研究枯否细胞并研究LXRα负调节炎症反应的可能机制。方法:原位胶原灌注从昆明雄性小鼠中分离得到库普弗细胞。将这些细胞分为4组:正常对照组,LPS治疗组,LXRα激动剂T0901317治疗组,LPS和T0901317联合治疗组。 LPS治疗组在RPMI 1640中的终浓度为1μg/ ml LPS处理并培养6 h,T0901317治疗组在RPMI 1640中的终浓度为5μg/ ml LPS处理并培养24 h,合并的治疗组在RPMI 1640中接受终浓度为1μg/ ml T0901317的预培养24 h,然后在RPMI 1640中进行终浓度为5μg/ ml LPS的培养6 h。所有组均培养30 H。实时荧光定量PCR和Western blotting检测LXRα,IRAK-4和NF-κB在mRNA和蛋白水平的表达,并通过ELISA检测TNF-α和IL-1β的水平。结果:T0901317组LXRαmRNA和蛋白水平最高,而LPS组最低(P <0.05)。联合治疗组IRAK4,NF-κBmRNA和蛋白水平明显低于LPS组(P <0.05)。 LPS组TNF-α和IL-1水平最高(P <0.05),而对照组,T0901317组和联合治疗组差异无统计学意义(P> 0.05)。结论:这些日期表明,LXR激动剂可以有效地上调LXRa mRNA和蛋白的表达并抑制炎症反应。这可能是通过在mRNA和蛋白质水平下调IRAK4和NF-κB的表达来实现的。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号